A PYMNTS Company

China: Bayer latest multinational to come under competition watch

By  |  September 15, 2013

German pharmaceutical giant Bayer confirmed Friday it is the subject of an antitrust investigation by Chinese regulators, though details of the probe are scarce.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    A spokesperson for Bayer told reporters that a local unit of the Administration for Industry and Commerce searched Bayer offices following competition concerns; the spokesperson said Bayer is “fully cooperating” with regulators.

    The investigation comes at a time when reports say Chinese competition regulators are zeroing-in on multinational firms and cracking down on certain sectors of the market, including the pharmaceutical industry.

    Full Content: Pharma Times

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.